“Distinct molecular mechanisms were identified for fenugreek: FE inhibited the expression of TYMS1 and TK1, synergizing with the chemotherapeutic drug 5-fluorouracil ( 5-FU ); meanwhile, HFE inhibited lipid metabolism targets, leading to diminished intracellular lipid content.”